- Home
- / Pulike Biological Engineering
Pulike Biological Engineering
Stock Price
¥13
2024-10-29
Market Capitalization
¥4.4 B
2024-10-29
Revenue
¥1.1 B
FY, 2025
Pulike Biological Engineering Summary
Company Summary
- Overview
- Pulike Biological Engineering (普莱柯生物工程股份有限公司) is a company that develops, produces, and markets veterinary biological products and drugs. It offers vaccines, antibodies, disinfectants, and medicines for swine and poultry.
- Type
- Public
- Status
- Active
- Founded
- 1995
- Website
- http://www.pulike.com.cn
- Cybersecurity rating
Table of Contents
Pulike Biological Engineering Financials
Summary Financials
- Revenue (Q1, 2026)
- ¥244.6M
- Gross profit (Q1, 2026)
- ¥132.2M
- Net income (Q1, 2026)
- ¥35.7M
- Cash (Q1, 2026)
- ¥87.3M
- EBIT (Q1, 2026)
- ¥43.8M
- Enterprise value
- $4.4B
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026